A comparison of clinical outcomes from updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL) - Palomba, M L; Ghione, P; Patel, A R (Blood, 2021)